![A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma]()
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaShi, Yuankai; Song, Yongping; Qin, Yan; Zhang, Qingyuan; Han, Xiaohong; Hong, Xiaonan; Wang, Dong; Li, Wei; Zhang, Yang; Feng, Jifeng; Yang, Jianmin; Zhang, Huilai; Jin, Chuan; Yang, Yu; Hu, Jianda; Wang, Zhao; Jin, Zhengming; Su, Hang; Wang, Huaqing; Yang, Haiyan; Fu, Weijun; Zhang, Mingzhi; Zhang, Xiaohong; Chen, Yun; Ke, Xiaoyan; Liu, Li; Yu, Ding; Chen, Guoâan; Wang, Xiuli; Jin, Jie; Sun, Tao; Du, Xin; Cheng, Ying; Yi, Pingyong; Zhao, Xielan; Ma, Chaoming; Cheng, Jiancheng; Chai, Katherine; Luk, Alvin; Liu, Eugene; Zhang, Xin · Journal of Hematology & Oncology · 2020